400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Neuronal Signaling / Secretase / LY2811376
CAS No.: 1194044-20-6
Synonyms: LY2811376
LY2811376 is the first orally available non-peptidic β-secretase (BACE1) inhibitor with IC50 of 239 nM-249 nM, that acts to decrease Aβ secretion with EC50 of 300 nM, and demonstrates to have 10-fold selectivity towards BACE1 over BACE2, and more than 50-fold inhibition over other aspartic proteases including cathepsin D, pepsin, or renin.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00838084 | Alzheimer's Disease | Phase 1 | Completed | - | United States, California ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Glendale, California, United States Collapse << |
实验方案
技术信息
CAS号 | 1194044-20-6 | 储存条件 |
|
|||||||||||
分子式 | C15H14F2N4S | 运输 | 蓝冰 | |||||||||||
分子量 | 320.36 | 别名 | LY2811376 | |||||||||||
溶解度 |
|
动物实验配方 |
|
Cell Lines | Concentration | Assay Type | Time | Activity Description | Data Sources |
---|
HEK293 cells | - | Function assay | - | Inhibition of BACE1 in HEK293 cells expressing APPswedish mutant assessed as inhibition of amyloid beta production by ELISA, EC50=0.3 μM | 24704031 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00838084 | Alzheimer's Disease | Phase 1 | Completed | - | United States, California ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Glendale, California, United States Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网